The Clinical Effectiveness of Ranibizumab Treat and Extend Regimen in nAMD: Systematic Review and Network Meta-Analysis

INTRODUCTION: Neovascular age-related macular degeneration (nAMD) is a chronic eye condition that causes severe deterioration of vision and ultimately blindness. Two vascular endothelial growth factor inhibitors are approved for nAMD treatment in Europe: ranibizumab and aflibercept. The European lic...

Descripción completa

Detalles Bibliográficos
Autores principales: Danyliv, Andriy, Glanville, Julie, McCool, Rachael, Ferreira, Alberto, Skelly, Adrian, Jacob, Ruth Pulikottil
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2017
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5350194/
https://www.ncbi.nlm.nih.gov/pubmed/28188433
http://dx.doi.org/10.1007/s12325-017-0484-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5350194/
https://www.ncbi.nlm.nih.gov/pubmed/28188433
http://dx.doi.org/10.1007/s12325-017-0484-0

Ejemplares similares